Latest updates for Hemlibra

Fresh curated links around HEMLIBRA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Real-world study backs safety of Hemlibra for acquired hemophilia A
  • Hemlibra outperforms ITI in controlling bleeding in hemophilia A children
  • Data show hemophilia bleeds can be successfully treated while on Hympavzi

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hemophilianewstoday.com /1 week ago

Real-world study backs safety of Hemlibra for acquired hemophilia A

Hemlibra (emicizumab) alongside immunosuppressive therapy appears safe for use in acquired hemophilia A (AHA), according to initial results of a real-world study in Japan, the only...

Read source
hemophilianewstoday.com /1 month ago

Hemlibra outperforms ITI in controlling bleeding in hemophilia A children

Preventive treatment with Hemlibra (emicizumab) is associated with better bleeding control and lower medication costs compared with immune tolerance induction, or ITI, among childr...

Read source
hemophilianewstoday.com /1 week ago

Data show hemophilia bleeds can be successfully treated while on Hympavzi

In the large clinical trial that supported the 2024 approval of Hympavzi (marstacimab) for adults and children with hemophilia, use of the prophylactic injection therapy was found...

Read source
hemophilianewstoday.com /2 weeks ago

Hympavzi now approved for more hemophilia patients in Europe

The European Commission has approved Hympavzi (marstacimab) to treat certain people with hemophilia A or hemophilia B who have inhibitors, the therapy’s maker, Pfizer, announced. H...

Read source
hemophilianewstoday.com /3 weeks ago

Denecimig excels at reducing bleeds in hemophilia A patients: Study

Denecimig (Mim8) was significantly better than on-demand or standard preventive treatments at reducing bleeding episodes in people with hemophilia A, regardless of inhibitor status...

Read source
jvir.org /4 weeks ago

Abstract No. LBA9 A Prospective Multicenter Single-Arm Study to Evaluate the Safety and Effectiveness of Embraceâ„¢ Hydr...

A prospective, single-arm, multicenter study to evaluate the safety and effectiveness of Embrace Hydrogel Embolic System (HES), for transcatheter embolization of peripheral arteria...

Read source
hemophilianewstoday.com /1 month ago

Single infusion of Roctavian linked to fewer bleeds in hemophilia A

Roctavian (valoctocogene roxaparvovec-rvox) was associated with fewer bleeding episodes and less need for preventive treatment, or prophylaxis, in most adult men with severe hemoph...

Read source
hemophilianewstoday.com /1 month ago

Confident protection from hemophilia A

The post Confident protection from hemophilia A appeared first on Hemophilia News Today.

Read source
hemophilianewstoday.com /1 month ago

Most men with hem A bleed-free 5 years after 1 Roctavian dose

A single dose of the gene therapy Roctavian (valoctocogene roxaparvovec-rvox) continues to prevent bleeds and the need for preventive treatment (prophylaxis) for up to five years i...

Read source
hemophilianewstoday.com /1 month ago

FX activator may help with bleeding control in hemophilia A and B: Trials

Bemiltenase alfa, an experimental factor X (FX) activator, helped with on-demand bleeding control for people with hemophilia A and B who had developed inhibitors against standard f...

Read source
bioengineer.org /2 weeks ago

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

In a groundbreaking advancement for gene therapy, researchers have unveiled two novel bioengineered AAV8 vectors—HMR-001 and its codon-optimized counterpart HMR-001z—that demonstra...

Read source
hemophilianewstoday.com /4 days ago

What to do during a bleeding emergency with hemophilia

When you or someone you love has hemophilia, even what seems like a minor bleed can quickly become serious. Knowing how to recognize a bleeding emergency and what steps to take can...

Read source
cnbc.com /4 days ago

Goldman says this biotech stock will be a winner thanks to a one-of-a-kind treatment

Hemab Therapeutics is likely to gain ground as its treatment for a pair of rare bleeding disorders shows signs of efficacy, per Goldman Sachs.

Read source
hemophilianewstoday.com /1 week ago

Prophylaxis and on-demand treatment for hemophilia: How doctors decide

After a hemophilia diagnosis, people typically work with their care team to develop a tailored treatment plan. This will likely involve considering both preventive (prophylactic) a...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Hemlibra

bioengineer.org

Recent coverage from public sources
Public source

hemophilianewstoday.com

Recent coverage from public sources
Public source

search.cnbc.com

Recent coverage from public sources
Public source

jvir.org

Recent coverage from public sources
Public source

Related searches

News hemophilia A HEMLIBRA Hympavzi Roctavian treatment Health Mim8 acquired hemophilia bleed prevention children with hemophilia gene therapy

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing